145 related articles for article (PubMed ID: 36930126)
1. Adverse events of a third dose of BNT162b2 mRNA COVID-19 vaccine among Korean healthcare workers.
Lee DY; Kang DY; Kim E; Lee SJ; Baek JH; Lee JS; Park MY; Im JH
Medicine (Baltimore); 2023 Mar; 102(11):e33236. PubMed ID: 36930126
[TBL] [Abstract][Full Text] [Related]
2. Immunological responses and adverse reactions of the heterologous second booster dose of BNT162b2 after two-dose CoronaVac for COVID-19 vaccination in healthcare workers of Faculty of Medicine, Naresuan University.
Makanut S; Wangteeraprasert A; Jitpewngam W; Ngoenkam J; Pongcharoen S
Vaccine; 2023 Jun; 41(29):4335-4340. PubMed ID: 37301707
[TBL] [Abstract][Full Text] [Related]
3. Adverse Events with the Pfizer-BioNTech COVID-19 Vaccine among Korean Healthcare Workers.
Im JH; Kim E; Lee E; Seo Y; Lee Y; Jang Y; Yu S; Maeng Y; Park S; Park S; Kim J; Lee JS; Baek JH
Yonsei Med J; 2021 Dec; 62(12):1162-1168. PubMed ID: 34816647
[TBL] [Abstract][Full Text] [Related]
4. Safety and tolerability of the novel 2019 coronavirus disease (COVID-19) vaccines among people with epilepsy (PwE): A cross-sectional study.
Massoud F; Ahmad SF; Hassan AM; Alexander KJ; Al-Hashel J; Arabi M
Seizure; 2021 Nov; 92():2-9. PubMed ID: 34391030
[TBL] [Abstract][Full Text] [Related]
5. Adverse reactions to the BNT162b2 and mRNA-1273 mRNA COVID-19 vaccines in Japan.
Kitagawa H; Kaiki Y; Sugiyama A; Nagashima S; Kurisu A; Nomura T; Omori K; Akita T; Shigemoto N; Tanaka J; Ohge H
J Infect Chemother; 2022 Apr; 28(4):576-581. PubMed ID: 35058126
[TBL] [Abstract][Full Text] [Related]
6. An observational study of adverse drug reactions to COVID-19 vaccines reported to the New Mexico poison center hotline.
Tadfor Y; Nguyen-Hua N; Bennett H; Bos AJ; Smolinske SC
Clin Toxicol (Phila); 2023 Jan; 61(1):77-83. PubMed ID: 36458888
[TBL] [Abstract][Full Text] [Related]
7. Side effects of Pfizer/BioNTech (BNT162b2) COVID-19 vaccine reported by the Birzeit University community.
Abukhalil AD; Shatat SS; Abushehadeh RR; Al-Shami N; Naseef HA; Rabba A
BMC Infect Dis; 2023 Jan; 23(1):5. PubMed ID: 36604613
[TBL] [Abstract][Full Text] [Related]
8. Correlation of adverse effects and antibody responses following homologous and heterologous COVID19 prime-boost vaccinations.
Cheng A; Hsieh MJ; Chang SY; Ieong SM; Cheng CY; Sheng WH; Chang SC
J Formos Med Assoc; 2023 May; 122(5):384-392. PubMed ID: 36564299
[TBL] [Abstract][Full Text] [Related]
9. Adverse Reactions of the Second Dose of the BNT162b2 mRNA COVID-19 Vaccine in Healthcare Workers in Korea.
Lee YW; Lim SY; Lee JH; Lim JS; Kim M; Kwon S; Joo J; Kwak SH; Kim EO; Jung J; Kwon HS; Kim TB; Kim SH; Bae S
J Korean Med Sci; 2021 May; 36(21):e153. PubMed ID: 34060261
[TBL] [Abstract][Full Text] [Related]
10. Adverse Events in Healthcare Workers after the First Dose of ChAdOx1 nCoV-19 or BNT162b2 mRNA COVID-19 Vaccination: a Single Center Experience.
Kim SH; Wi YM; Yun SY; Ryu JS; Shin JM; Lee EH; Seo KH; Lee SH; Peck KR
J Korean Med Sci; 2021 Apr; 36(14):e107. PubMed ID: 33847085
[TBL] [Abstract][Full Text] [Related]
11. Safety Monitoring after the BNT162b2 COVID-19 Vaccine among Adults Aged 75 Years or Older.
Choi YY; Kim MK; Kwon HC; Kim GH
J Korean Med Sci; 2021 Nov; 36(45):e318. PubMed ID: 34811980
[TBL] [Abstract][Full Text] [Related]
12. Impact of Sex and Age on mRNA COVID-19 Vaccine-Related Side Effects in Japan.
Mori M; Yokoyama A; Shichida A; Sasuga K; Maekawa T; Moriyama T
Microbiol Spectr; 2022 Dec; 10(6):e0130922. PubMed ID: 36314943
[TBL] [Abstract][Full Text] [Related]
13. Safety of COVID-19 vaccines.
Al Khames Aga QA; Alkhaffaf WH; Hatem TH; Nassir KF; Batineh Y; Dahham AT; Shaban D; Al Khames Aga LA; Agha MYR; Traqchi M
J Med Virol; 2021 Dec; 93(12):6588-6594. PubMed ID: 34270094
[TBL] [Abstract][Full Text] [Related]
14. A retrospective evaluation of side-effects associated with the booster dose of Pfizer-BioNTech/BNT162b2 COVID-19 vaccine among females in Eastern Province, Saudi Arabia.
Hassan YAM; Daud Ali M; Al-Eid RR; Al-Ghuraya FA; Essa Alqasimi Z; Ahmad A; Eltrafi Z; Ghosn SA
Vaccine; 2022 Nov; 40(49):7087-7096. PubMed ID: 36404426
[TBL] [Abstract][Full Text] [Related]
15. Myositis developing after Covid-19 mRNA vaccine: Case Report.
Tosunoğlu B; Güneş HN; Çokal BG; Yoldaş TK
Acta Neurol Taiwan; 2023 Jun; 32(2)():79-81. PubMed ID: 37198512
[TBL] [Abstract][Full Text] [Related]
16. Adverse reactions to BNT162b2 mRNA COVID-19 vaccine in medical staff with a history of allergy.
Inoue S; Igarashi A; Morikane K; Hachiya O; Watanabe M; Kakehata S; Sato S; Ueno Y
Respir Investig; 2022 Mar; 60(2):248-255. PubMed ID: 34920980
[TBL] [Abstract][Full Text] [Related]
17. Short-term outcome of pregnant women vaccinated with BNT162b2 mRNA COVID-19 vaccine.
Bookstein Peretz S; Regev N; Novick L; Nachshol M; Goffer E; Ben-David A; Asraf K; Doolman R; Levin EG; Regev Yochay G; Yinon Y
Ultrasound Obstet Gynecol; 2021 Sep; 58(3):450-456. PubMed ID: 34198360
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of COVID-19 vaccines (Sputnik V, AZD-1222, and Covaxin) side effects among healthcare workers in Birjand city, Iran.
Zare H; Rezapour H; Mahmoodzadeh S; Fereidouni M
Int Immunopharmacol; 2021 Dec; 101(Pt B):108351. PubMed ID: 34801416
[TBL] [Abstract][Full Text] [Related]
19. Reactions following Pfizer-BioNTech COVID-19 mRNA vaccination and related healthcare encounters among 7,077 children aged 5-11 years within an integrated healthcare system.
Malden DE; Gee J; Glenn S; Li Z; Mercado C; Ogun OA; Kim S; Lewin BJ; Ackerson BK; Jazwa A; Weintraub ES; McNeil MM; Tartof SY
Vaccine; 2023 Jan; 41(2):315-322. PubMed ID: 36351861
[TBL] [Abstract][Full Text] [Related]
20. Adverse events after BNT162b2 mRNA COVID-19 vaccination in health care workers and medical students in Japan.
Namiki T; Komine-Aizawa S; Takada K; Takano C; Trinh QD; Hayakawa S
J Infect Chemother; 2022 Aug; 28(8):1220-1224. PubMed ID: 35577684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
